{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:23:38Z","timestamp":1792185818907,"version":"4.4.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.vaccine.2008.11.049","type":"journal-article","created":{"date-parts":[[2008,12,24]],"date-time":"2008-12-24T08:40:52Z","timestamp":1230108052000},"page":"I49-I55","source":"Crossref","is-referenced-by-count":17,"special_numbering":"S8","title":["Contribution of interactions between complement inhibitor C4b-binding protein and pathogens to their ability to establish infection with particular emphasis on Neisseria gonorrhoeae"],"prefix":"10.1016","volume":"26","author":[{"given":"Anna M.","family":"Blom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Ram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vaccine.2008.11.049_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0167-5699(91)90003-C","article-title":"Complement deficiency and disease","volume":"12","author":"Morgan","year":"1991","journal-title":"Immunol Today"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2008.11.049_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0015-0282(16)44117-8","article-title":"The presence of complement in human cervical mucus and its possible relevance to infertility in women with complement-dependent sperm-immobilizing antibodies","volume":"32","author":"Price","year":"1979","journal-title":"Fertil Steril"},{"issue":"April (3)","key":"10.1016\/j.vaccine.2008.11.049_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/oxfordjournals.humrep.a136698","article-title":"Immunology of spermatozoa and cervical mucus","volume":"3","author":"Schumacher","year":"1988","journal-title":"Hum Reprod"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2008.11.049_bib4","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/oxfordjournals.humrep.a138768","article-title":"Investigations on the cell type responsible for the endometrial secretion of complement component 3 (C3)","volume":"9","author":"Bischof","year":"1994","journal-title":"Hum Reprod"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2008.11.049_bib5","first-page":"1641","article-title":"Localization of the expression of complement component 3 in the human endometrium by in situ hybridization","volume":"81","author":"Sayegh","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2008.11.049_bib6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1086\/314545","article-title":"Complement processing and immunoglobulin binding to Neisseria gonorrhoeae determined in vitro simulates in vivo effects","volume":"179","author":"McQuillen","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.11.049_bib7","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1073\/pnas.76.12.6596","article-title":"Modulation of the classical pathway C3 convertase by plasma protein C4b binding and C3b inactivator","volume":"76","author":"Gigli","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.11.049_bib8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0161-5890(02)00213-4","article-title":"CCP1-4 of the C4b-binding protein \u03b1-chain are required for Factor I mediated cleavage of C3b","volume":"39","author":"Blom","year":"2003","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2008.11.049_bib9","doi-asserted-by":"crossref","first-page":"9349","DOI":"10.1021\/bi025980+","article-title":"Structural requirements for the intra-cellular subunit polymerization of the complement inhibitor C4b-binding protein","volume":"41","author":"Kask","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2008.11.049_bib10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1034\/j.1600-065X.2001.1800113.x","article-title":"Structure and flexibility of the multiple domain proteins that regulate complement activation","volume":"180","author":"Kirkitadze","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2008.11.049_bib11","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1073\/pnas.80.11.3461","article-title":"Visualization of human C4b-binding protein and its complexes with vitamin K-dependent protein S and complement protein C4b","volume":"80","author":"Dahlb\u00e4ck","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2008.11.049_bib12","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.4049\/jimmunol.180.9.6385","article-title":"A novel non-synonymous polymorphism (p Arg240His) in C4b-binding protein is associated with atypical hemolytic uremic syndrome and leads to impaired alternative pathway cofactor activity","volume":"180","author":"Blom","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.11.049_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-5793(89)81492-9","article-title":"S binding in relation to the subunit composition of human C4b-binding protein","volume":"259","author":"Hillarp","year":"1989","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2008.11.049_bib14","doi-asserted-by":"crossref","first-page":"12759","DOI":"10.1016\/S0021-9258(18)37818-9","article-title":"Novel subunit in C4b-binding protein required for protein S binding","volume":"263","author":"Hillarp","year":"1988","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.vaccine.2008.11.049_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000463131","article-title":"C4b-binding protein, a regulatory component of the classical pathway of complement, is an acute-phase protein and is elevated in systemic lupus erythematosus","volume":"7","author":"Barnum","year":"1990","journal-title":"Complement Inflammat"},{"key":"10.1016\/j.vaccine.2008.11.049_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4049\/jimmunol.89.3.307","article-title":"Current knowledge of type-specific M antigens of group A streptococci","volume":"89","author":"Lancefield","year":"1962","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.11.049_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1128\/CMR.2.3.285","article-title":"M protein: molecular design and biological behavior","volume":"2","author":"Fischetti","year":"1989","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2008.11.049_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4049\/jimmunol.154.1.375","article-title":"Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system","volume":"154","author":"Thern","year":"1995","journal-title":"J Immunol"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2008.11.049_bib19","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1073\/pnas.85.5.1657","article-title":"Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H","volume":"85","author":"Horstmann","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.11.049_bib20","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.4049\/jimmunol.157.7.3021","article-title":"A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP","volume":"157","author":"Johnsson","year":"1996","journal-title":"J Immunol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2008.11.049_bib21","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1371\/journal.ppat.0020047","article-title":"Extreme sequence divergence but conserved ligand-binding specificity in Streptococcus pyogenes M protein","volume":"2","author":"Persson","year":"2006","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2008.11.049_bib22","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.4049\/jimmunol.157.11.4935","article-title":"Binding of human complement component C4b-binding protein (C4BP) to Streptococcus pyogenes involves the C4b-binding site","volume":"157","author":"Accardo","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.11.049_bib23","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.4049\/jimmunol.164.10.5328","article-title":"Human C4b-binding protein has overlapping but not identical binding sites for C4b and streptococcal M proteins","volume":"164","author":"Blom","year":"2000","journal-title":"J Immunol"},{"issue":"February (6)","key":"10.1016\/j.vaccine.2008.11.049_bib24","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1074\/jbc.M511563200","article-title":"Human C4b-binding protein, structural basis for interaction with streptococcal M protein, a major bacterial virulence factor","volume":"281","author":"Jenkins","year":"2006","journal-title":"J Biol Chem"},{"issue":"April (14)","key":"10.1016\/j.vaccine.2008.11.049_bib25","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1021\/bi052455c","article-title":"Streptococcal M protein: structural studies of the hypervariable region, free and bound to human C4BP","volume":"45","author":"Andre","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2008.11.049_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0161-5890(91)90147-C","article-title":"Binding properties of protein Arp, a bacterial IgA-receptor","volume":"28","author":"\u00c5kerstr\u00f6m","year":"1991","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2008.11.049_bib27","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.4049\/jimmunol.167.7.3870","article-title":"Isolated hypervariable regions derived from streptococcal M proteins specifically bind human C4b-binding protein: implications for antigenic variation","volume":"167","author":"Morfeldt","year":"2001","journal-title":"J Immunol"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2008.11.049_bib28","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1084\/jem.20030543","article-title":"Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein","volume":"198","author":"Carlsson","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.11.049_bib29","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.4049\/jimmunol.169.11.6352","article-title":"A novel interaction of outer membrane protein A with C4b-binding protein mediates serum resistance of Escherichia coli K1","volume":"169","author":"Prasadarao","year":"2002","journal-title":"J Immunol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2008.11.049_bib30","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1172\/JCI115965","article-title":"The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat","volume":"90","author":"Kim","year":"1992","journal-title":"J Clin Invest"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2008.11.049_bib31","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1128\/IAI.59.7.2252-2258.1991","article-title":"Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1","volume":"59","author":"Weiser","year":"1991","journal-title":"Infect Immun"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2008.11.049_bib32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2567.2006.02323.x","article-title":"Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation","volume":"117","author":"Wooster","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2008.11.049_bib33","article-title":"Effects of complement regulators bound to Escherichia coli K1 and Group B Streptococcus on the interaction with host cells","author":"Maruvada","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2008.11.049_bib34","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1128\/IAI.65.9.3638-3643.1997","article-title":"Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin","volume":"65","author":"Bergg\u00e5rd","year":"1997","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2008.11.049_bib35","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1002\/1521-4141(200109)31:9<2771::AID-IMMU2771>3.0.CO;2-0","article-title":"Bordetella pertussis binds to human C4b-binding protein (C4BP) at a site similar to that used by the natural ligand C4b","volume":"31","author":"Bergg\u00e5rd","year":"2001","journal-title":"Eur J Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2008.11.049_bib36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF01962067","article-title":"Impact of the changing epidemiology of fungal infections in the 1990s","volume":"11","author":"Pfaller","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2008.11.049_bib37","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/clinids\/21.4.897","article-title":"Opportunistic candidiasis: an epidemic of the 1980s","volume":"21","author":"Fisher-Hoch","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2008.11.049_bib38","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1128\/IAI.70.9.5185-5192.2002","article-title":"The yeast Candida albicans binds complement regulators factor H and FHL-1","volume":"70","author":"Meri","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.049_bib39","doi-asserted-by":"crossref","first-page":"6633","DOI":"10.1128\/IAI.72.11.6633-6641.2004","article-title":"The yeast and hyphal forms of Candida albicans bind complement regulator C4b-binding protein","volume":"11","author":"Meri","year":"2004","journal-title":"Infect Immun"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2008.11.049_bib40","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.molimm.2007.08.011","article-title":"Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein","volume":"45","author":"Vogl","year":"2008","journal-title":"Mol Immunol"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2008.11.049_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/MMBR.60.2.267-279.1996","article-title":"Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response","volume":"60","author":"Murphy","year":"1996","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.vaccine.2008.11.049_bib42","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.4049\/jimmunol.173.7.4598","article-title":"The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b-binding protein through ubiquitous surface proteins A1 and A2","volume":"173","author":"Nordstr\u00f6m","year":"2004","journal-title":"J Immunol"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2008.11.049_bib43","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.4049\/jimmunol.178.10.6359","article-title":"Interaction with C4b-binding protein contributes to nontypeable Haemophilus influenzae serum resistance","volume":"178","author":"Hallstrom","year":"2007","journal-title":"J Immunol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2008.11.049_bib44","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1128\/IAI.00007-06","article-title":"Relapsing fever spirochetes Borrelia recurrentis and B. duttonii acquire complement regulators C4b-binding protein and factor H","volume":"74","author":"Meri","year":"2006","journal-title":"Infect Immun"},{"issue":"March (11)","key":"10.1016\/j.vaccine.2008.11.049_bib45","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1074\/jbc.M007994200","article-title":"The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi","volume":"276","author":"Hellwage","year":"2001","journal-title":"J Biol Chem"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2008.11.049_bib46","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/1521-4141(200106)31:6<1674::AID-IMMU1674>3.0.CO;2-2","article-title":"Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1\/reconectin and Factor H","volume":"31","author":"Kraiczy","year":"2001","journal-title":"Eur J Immunol"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2008.11.049_bib47","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.4049\/jimmunol.174.10.6299","article-title":"Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis","volume":"174","author":"Jarva","year":"2005","journal-title":"J Immunol"},{"issue":"June (Suppl. 1)","key":"10.1016\/j.vaccine.2008.11.049_bib48","first-page":"S12","article-title":"Global prevalence and incidence estimates of selected curable STDs","volume":"74","author":"Gerbase","year":"1998","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2008.11.049_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00002030-199301000-00015","article-title":"Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study","volume":"7","author":"Laga","year":"1993","journal-title":"AIDS"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2008.11.049_bib50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00005792-198311000-00005","article-title":"Disseminated gonococcal infection: a prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms","volume":"62","author":"O\u2019Brien","year":"1983","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.vaccine.2008.11.049_bib51","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.4049\/jimmunol.124.5.2105","article-title":"Natural serum bactericidal activity against Neisseria gonorrhoeae from disseminated, locally invasive and uncomplicated disease","volume":"124","author":"Rice","year":"1980","journal-title":"J Immunol"},{"issue":"July (5256)","key":"10.1016\/j.vaccine.2008.11.049_bib52","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/227382a0","article-title":"Gonococci in urethral exudates possess a virulence factor lost on subculture","volume":"227","author":"Ward","year":"1970","journal-title":"Nature"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2008.11.049_bib53","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0882-4010(88)90103-9","article-title":"Cytidine 5\u2019-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum","volume":"5","author":"Parsons","year":"1988","journal-title":"Microb Pathog"},{"issue":"5","key":"10.1016\/j.vaccine.2008.11.049_bib54","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1084\/jem.187.5.743","article-title":"A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae","volume":"187","author":"Ram","year":"1998","journal-title":"J Exp Med"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2008.11.049_bib55","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/infdis\/162.2.506","article-title":"Modification by sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis","volume":"162","author":"Apicella","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.11.049_bib56","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1084\/jem.188.4.671","article-title":"Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae","volume":"4","author":"Ram","year":"1998","journal-title":"J Exp Med"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2008.11.049_bib57","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0966-842X(02)00037-9","article-title":"The role of porins in neisserial pathogenesis and immunity","volume":"11","author":"Massari","year":"2003","journal-title":"Trends Microbiol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2008.11.049_bib58","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/infdis\/150.1.44","article-title":"Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I","volume":"150","author":"Knapp","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.11.049_bib59","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1084\/jem.193.3.281","article-title":"Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae","volume":"193","author":"Ram","year":"2001","journal-title":"J Exp Med"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2008.11.049_bib60","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4049\/jimmunol.179.1.540","article-title":"Molecular characterization of the interaction between porins of Neisseria gonorrhoeae and C4b-binding protein","volume":"179","author":"Jarva","year":"2007","journal-title":"J Immunol"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2008.11.049_bib61","first-page":"145","article-title":"Epidemiological analysis of Neisseria gonorrhoeae in the Federal Republic of Germany by auxotyping and serological classification using monoclonal antibodies","volume":"62","author":"Kohl","year":"1986","journal-title":"Genitourin Med"},{"issue":"July (4)","key":"10.1016\/j.vaccine.2008.11.049_bib62","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF00144994","article-title":"Epidemiological typing of Neisseria gonorrhoeae: a comparative analysis of three monoclonal antibody serotyping panels","volume":"7","author":"Moyes","year":"1991","journal-title":"Eur J Epidemiol"},{"issue":"September (18)","key":"10.1016\/j.vaccine.2008.11.049_bib63","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1073\/pnas.85.18.6841","article-title":"Genetics of protein I of Neisseria gonorrhoeae: construction of hybrid porins","volume":"85","author":"Carbonetti","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.11.049_bib64","doi-asserted-by":"crossref","first-page":"19237","DOI":"10.1074\/jbc.274.27.19237","article-title":"A cluster of positively charged amino acids in the N-terminal modules of the C4BP \u03b1-chain is crucial for C4b binding and factor I cofactor function","volume":"274","author":"Blom","year":"1999","journal-title":"J Biol Chem"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2008.11.049_bib65","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1128\/IAI.01109-06","article-title":"Heptose I glycan substitutions on Neisseria gonorrhoeae lipooligosaccharide influence C4b-binding protein binding and serum resistance","volume":"75","author":"Ram","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.11.049_bib66","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.4049\/jimmunol.166.11.6764","article-title":"A novel interaction between type IV pili of Neisseria gonorrhoeae and the human complement regulator C4b-binding protein","volume":"166","author":"Blom","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.11.049_bib67","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JB.96.3.596-605.1968","article-title":"Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro","volume":"96","author":"Kellogg","year":"1968","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2008.11.049_bib68","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1084\/jem.165.5.1344","article-title":"Gonococcal pilin variants in experimental gonorrhea","volume":"165","author":"Swanson","year":"1987","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.11.049_bib69","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/j.1460-2075.1991.tb07970.x","article-title":"Phase variation of gonococcal pili by frameshift mutation in pilC, a novel gene for pilus assembly","volume":"10","author":"Jonsson","year":"1991","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2008.11.049_bib70","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1073\/pnas.89.8.3204","article-title":"Neisseria gonorrhoeae PilC expression provides a selective mechanism for structural diversity of pili","volume":"89","author":"Jonsson","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.11.049_bib71","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1046\/j.1365-2958.1997.4841857.x","article-title":"Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria","volume":"25","author":"K\u00e4llstr\u00f6m","year":"1997","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2008.11.049_bib72","doi-asserted-by":"crossref","unstructured":"Spijkers PP, Denis CV, Blom AM, Lenting PJ. Cellular uptake of C4b-binding protein is mediated by heparan sulfate proteoglycans and CD91\/LDL receptor-related protein. Eur J Immunol 2008;38(3):809\u201317.","DOI":"10.1002\/eji.200737722"},{"key":"10.1016\/j.vaccine.2008.11.049_bib73","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1074-7613(03)00149-3","article-title":"C4b-binding protein (C4BP) activates B cells through the CD40 receptor","volume":"18","author":"Brodeur","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2008.11.049_bib74","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.4049\/jimmunol.169.5.2580","article-title":"Vitamin K-dependent protein S localizing complement regulator C4b-binding protein to the surface of apoptotic cells","volume":"169","author":"Webb","year":"2002","journal-title":"J Immunol"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2008.11.049_bib75","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1128\/JVI.79.12.7478-7491.2005","article-title":"Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity","volume":"79","author":"Shayakhmetov","year":"2005","journal-title":"J Virol"},{"issue":"November (47)","key":"10.1016\/j.vaccine.2008.11.049_bib76","doi-asserted-by":"crossref","first-page":"17142","DOI":"10.1073\/pnas.0506471102","article-title":"Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection","volume":"102","author":"Ngampasutadol","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"April (Suppl.)","key":"10.1016\/j.vaccine.2008.11.049_bib77","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1128\/CMR.2.Suppl.S56","article-title":"Animal models for pathogenic Neisseria species","volume":"2","author":"Arko","year":"1989","journal-title":"Clin Microbiol Rev"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2008.11.049_bib78","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.4049\/jimmunol.180.5.3426","article-title":"Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion","volume":"180","author":"Ngampasutadol","year":"2008","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08015983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08015983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T01:14:09Z","timestamp":1684804449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08015983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":78,"alternative-id":["S0264410X08015983"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}